In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...

People with type 2 diabetes are more likely to develop heart failure, but the reasons are not fully explained by cholesterol, blood pressure and blocked arteries alone. A new study adds another piece ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...

Hearts of young cyclists show greater exercise-related adaptation, including more left ventricular enlargement and changes on ...